Skip to main content

Table 3 Toxicity documentation: measurement points t1-t8 (Percentages)

From: Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification

Scale

Mesurement-point

Grade 0

Grade 1

Grade 2

Grade 3

Grade 4

Axilla: Pain

t1

51.61%

39.78%

8.60%

0.00%

0.00%

 

t2

52.17%

40.22%

7.61%

0.00%

0.00%

 

t3

53.26%

41.30%

5.43%

0.00%

0.00%

 

t4

58.06%

38.71%

3.23%

0.00%

0.00%

 

t5

56.52%

42.39%

1.09%

0.00%

0.00%

 

t6

63.74%

35.16%

1.10%

0.00%

0.00%

 

t8

85.71%

14.29%

0.00%

0.00%

0.00%

Axilla: Hair loss

t1

100.00%

0.00%

0.00%

0.00%

xxx

 

t2

98.91%

1.09%

0.00%

0.00%

xxx

 

t3

100.00%

0.00%

0.00%

0.00%

xxx

 

t4

97.85%

1.08%

1.08%

0.00%

xxx

 

t5

98.91%

1.09%

0.00%

0.00%

xxx

 

t6

100.00%

0.00%

0.00%

0.00%

xxx

 

t8

100.00%

0.00%

0.00%

0.00%

xxx

Axilla: sweat gland function

t1

100.00%

0.00%

0.00%

0.00%

xxx

 

t2

100.00%

0.00%

0.00%

0.00%

xxx

 

t3

100.00%

0.00%

0.00%

0.00%

xxx

 

t4

100.00%

0.00%

0.00%

0.00%

xxx

 

t5

100.00%

0.00%

0.00%

0.00%

xxx

 

t6

100.00%

0.00%

0.00%

0.00%

xxx

 

t8

100.00%

0.00%

0.00%

0.00%

xxx

Arm: Lymphedema

t1

62.37%

37.63%

0.00%

0.00%

0.00%

 

t2

60.87%

38.04%

1.09%

0.00%

0.00%

 

t3

63.04%

36.96%

0.00%

0.00%

0.00%

 

t4

61.29%

38.71%

0.00%

0.00%

0.00%

 

t5

61.96%

38.04%

0.00%

0.00%

0.00%

 

t6

62.64%

37.36%

0.00%

0.00%

0.00%

 

t8

60.00%

37.14%

2.86%

0.00%

0.00%

Arm: Function

t1

39.78%

53.76%

6.45%

0.00%

0.00%

 

t2

42.39%

54.35%

3.26%

0.00%

0.00%

 

t3

46.15%

52.75%

1.10%

0.00%

0.00%

 

t4

48.39%

51.61%

0.00%

0.00%

0.00%

 

t5

53.26%

46.74%

0.00%

0.00%

0.00%

 

t6

59.34%

39.56%

1.10%

0.00%

0.00%

 

t8

71.43%

28.57%

0.00%

0.00%

0.00%